Ryvu Therapeutics Correlations
| RVU Stock | 45.30 1.15 2.48% |
The current 90-days correlation between Ryvu Therapeutics and Echo Investment SA is 0.22 (i.e., Modest diversification). The correlation of Ryvu Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Ryvu Therapeutics Correlation With Market
Good diversification
The correlation between Ryvu Therapeutics SA and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ryvu Therapeutics SA and DJI in the same portfolio, assuming nothing else is changed.
Ryvu |
The ability to find closely correlated positions to Ryvu Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ryvu Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ryvu Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ryvu Therapeutics SA to buy it.
Moving together with Ryvu Stock
Moving against Ryvu Stock
| 0.78 | CEZ | CEZ as | PairCorr |
| 0.56 | UCG | UniCredit SpA | PairCorr |
| 0.55 | DNP | Dino Polska SA | PairCorr |
| 0.49 | SAN | Banco Santander SA | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ryvu Stock performing well and Ryvu Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ryvu Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ECH | 1.34 | 0.10 | (0.01) | 46.94 | 2.24 | 2.86 | 10.60 | |||
| GRX | 2.56 | (0.06) | 0.00 | (0.10) | 0.00 | 4.98 | 35.53 | |||
| CLD | 2.21 | 0.14 | (0.01) | (0.14) | 2.56 | 4.00 | 16.54 | |||
| CRI | 2.12 | (0.26) | 0.00 | 1.35 | 0.00 | 4.83 | 16.49 | |||
| GTC | 1.46 | 0.09 | 0.00 | 0.50 | 1.48 | 4.14 | 17.50 | |||
| K2P | 2.96 | (0.08) | (0.01) | 0.03 | 4.07 | 10.28 | 26.37 | |||
| QNT | 1.75 | 0.03 | (0.01) | 0.21 | 2.88 | 8.70 | 28.01 |
Ryvu Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ryvu Therapeutics stock to make a market-neutral strategy. Peer analysis of Ryvu Therapeutics could also be used in its relative valuation, which is a method of valuing Ryvu Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |